文章：

日本不适合移植的多发性骨髓瘤患者中达雷妥尤单抗、来那度胺与地塞米松不同序贯方案的真实世界治疗结果

Real-World Treatment Outcomes of Different Sequencing Options with Daratumumab, Lenalidomide, and Dexamethasone in Patients with Transplant-Ineligible Multiple Myeloma in Japan

原文发布日期：22 April 2025

DOI: 10.3390/cancers17091389

类型: Article

开放获取: 是

英文摘要：

Multiple myeloma (MM) is a hematologic malignancy characterized by monoclonal proliferation of plasma cells that leads to bone disease, including lytic lesions and osteoporosis [...]

摘要翻译： 

多发性骨髓瘤（MM）是一种血液系统恶性肿瘤，其特征为浆细胞单克隆性增殖，进而引发包括溶骨性病变和骨质疏松在内的骨骼疾病。

原文链接：

Real-World Treatment Outcomes of Different Sequencing Options with Daratumumab, Lenalidomide, and Dexamethasone in Patients with Transplant-Ineligible Multiple Myeloma in Japan